Leverage key opinion leaders for better market access
For biopharma market access teams, engaging Key Opinion Leaders (KOLs) who help structure guidelines and downstream payer polices may be a high impact but untapped resource. Learn how biopharma manufacturers should consider including network mapping analysis and tailoring outreach efforts to gain better access to compelling evidence and insights.
The ‘five pandemics’ driving 1 million U.S. Covid deaths; telehealth aims to fix Paxlovid's prescription bottleneck
Reviewed by Knowledge World
on
May 10, 2022
Rating: 5
No comments